Issue 72, 2017

Biotin-tagged platinum(iv) complexes as targeted cytostatic agents against breast cancer cells

Abstract

A biotin-guided platinumIV complex is highly cytotoxic against breast cancer cells but hypotoxic against mammary epithelial cells. The mono-biotinylated PtIV complex is superior to the di-biotinylated one and hence a promising drug candidate for the targeted therapy of breast cancer.

Graphical abstract: Biotin-tagged platinum(iv) complexes as targeted cytostatic agents against breast cancer cells

Supplementary files

Article information

Article type
Communication
Submitted
10 Jul 2017
Accepted
15 Aug 2017
First published
15 Aug 2017

Chem. Commun., 2017,53, 9971-9974

Biotin-tagged platinum(IV) complexes as targeted cytostatic agents against breast cancer cells

N. Muhammad, N. Sadia, C. Zhu, C. Luo, Z. Guo and X. Wang, Chem. Commun., 2017, 53, 9971 DOI: 10.1039/C7CC05311H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements